TNFRSF17 and Miyoshi myopathy: These cells have significantly lower BCMA expression than PCs [78], pDCs located in the bone marrow near MM cells to enhance their growth and survival [77], so the role of BCMA in pDCs causes further enhancement of the viability and drug resistance of MM cells [77].